Literature DB >> 7569549

[Second tumors in pediatric oncologic patients. Report of 5 cases].

M Jiménez1, P León, L Castro, C Azcona, L Sierrasesúmaga.   

Abstract

The dramatic progress observed in the survival of children treated for cancer in the last two decades due to the use of aggressive chemotherapy and radiotherapy has brought an increased incidence of second malignant tumors. Five clinical cases of second malignant neoplasms after a period of six months to seventeen years after diagnosis are presented. The second tumors observed were: one patient with malignant fibrous histiocytoma of the orbit after treatment bilateral retinoblastoma; one patient with multifocal osteosarcoma after cerebelli medullo-blastoma; one patient with Ewing's sarcoma of the fibula after neuroblastoma of the adrenal gland; one case of carcinoma of the thyroid gland after osteosarcoma of the femur and one patient with acute lymphoblastic leukemia after been treated of osteosarcoma of the femur. The genetic, immunologic and therapeutic risk factors are reviewed and analyzed.

Entities:  

Mesh:

Year:  1995        PMID: 7569549

Source DB:  PubMed          Journal:  Rev Med Univ Navarra        ISSN: 0556-6177


  4 in total

1.  Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.

Authors:  Sara M Federico; Heather B Allewelt; Sheri L Spunt; Melissa M Hudson; Jianrong Wu; Catherine A Billups; Jesse Jenkins; Victor M Santana; Wayne L Furman; Lisa M McGregor
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

2.  The role of fragile sites in sporadic papillary thyroid carcinoma.

Authors:  Laura W Dillon; Christine E Lehman; Yuh-Hwa Wang
Journal:  J Thyroid Res       Date:  2012-06-11

3.  Secondary thyroid papillary carcinoma in osteosarcoma patients: report of two cases.

Authors:  Min Suk Kim; Yoon Sang Sim; Soo-Yong Lee; Dae-Geun Jeon
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

Review 4.  Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.

Authors:  Naomi D Atkin; Heather M Raimer; Yuh-Hwa Wang
Journal:  Genes (Basel)       Date:  2019-10-12       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.